New Jersey A1823 mandates a two-year pilot program for NJT to equip light rail train sets in the southern part of the state with opioid antidotes.

New Jersey A1823 requires the New Jersey Transit Corporation to establish a two-year pilot program to supply opioid antidotes on every light rail train set operating in the southern part of the state. The program aims to respond to opioid overdoses. The corporation must obtain and distribute the antidotes in consultation with the Department of Health, stock each location with at least two doses, and ensure they are maintained and available during operation. Authorized employees, contractors, and staff members must perform routine checks, maintain records, and conduct necessary maintenance.

New Jersey A1823 mandates a two-year pilot program for NJT to equip light rail train sets in the southern part of the state with opioid antidotes.

New Jersey A1823 requires the New Jersey Transit Corporation to establish a two-year pilot program to supply opioid antidotes on every light rail train set operating in the southern part of the state. The program aims to respond to opioid overdoses. The corporation must obtain and distribute the antidotes in consultation with the Department of Health, stock each location with at least two doses, and ensure they are maintained and available during operation. Authorized employees, contractors, and staff members must perform routine checks, maintain records, and conduct necessary maintenance.